Designing a Strategy Trial for the Management of Gout: The Use of a Modified Delphi Panel

Disagreement exists between rheumatology and primary care societies regarding gout management. This paper describes a formal process for gathering input from stakeholders in the planning of a trial to compare gout management strategies.

[1]  M. Kolber,et al.  Treat‐to‐Target in Gout Management? Comment on the Article by FitzGerald et al , 2020, Arthritis & rheumatology.

[2]  G. Guyatt,et al.  2020 American College of Rheumatology Guideline for the Management of Gout , 2020, Arthritis & rheumatology.

[3]  R. Doughty,et al.  Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study , 2019, Arthritis & rheumatology.

[4]  S. Taddei,et al.  The difficult relationship between uric acid and cardiovascular disease. , 2019, European heart journal.

[5]  Hyon K. Choi,et al.  Effects of Febuxostat in Early Gout , 2017, Arthritis & rheumatology.

[6]  R. Terkeltaub,et al.  Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) , 2017, Nature Reviews Rheumatology.

[7]  Hyon K. Choi,et al.  Editorial: Do Not Let Gout Apathy Lead to Gouty Arthropathy , 2016, Arthritis & rheumatology.

[8]  F. Becce,et al.  2016 updated EULAR evidence-based recommendations for the management of gout , 2014, Annals of the rheumatic diseases.

[9]  M. Moxey-Mims,et al.  Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  L. Harrold,et al.  Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. , 2013, Rheumatology.

[11]  E. Bonora,et al.  Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function , 2011, Diabetes Care.

[12]  Hyon K. Choi,et al.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.

[13]  P. Lipsky,et al.  Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. , 2011, JAMA.

[14]  E. Barrett-Connor,et al.  Serum Uric Acid Levels Improve Prediction of Incident Type 2 Diabetes in Individuals With Impaired Fasting Glucose , 2009, Diabetes Care.

[15]  Naoyuki Kamatani,et al.  A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. , 2004, Arthritis and rheumatism.

[16]  J. Drennan,et al.  Cognitive interviewing: verbal data in the design and pretesting of questionnaires. , 2003, Journal of advanced nursing.

[17]  B. Burnand,et al.  The RAND/UCLA Appropriateness Method User's Manual , 2001 .

[18]  J. Spencer,et al.  Clarifying the concepts of confidence and competence to produce appropriate self‐evaluation measurement scales , 2000, Medical education.

[19]  J Stewart,et al.  Identifying appropriate tasks for the preregistration year: modified Delphi technique , 1999, BMJ.

[20]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .

[21]  R. Brook,et al.  Consensus methods: characteristics and guidelines for use. , 1984, American journal of public health.

[22]  D. Petroni.  [Therapy of gout]. , 1972, La Clinica terapeutica.